Management & Regulatory

The relentless cycle of monitoring, calculating, and dosing that defines daily life for millions with type 1 diabetes has long been a significant source of mental and emotional strain. Managing the condition often feels like a full-time job, where every meal and snack requires meticulous

The medical community continues to face a significant challenge in treating idiopathic pulmonary fibrosis, a terminal respiratory condition that affects hundreds of thousands of individuals worldwide by scarring lung tissue and making breathing increasingly difficult over time. Current

For families and physicians navigating the devastating course of thymidine kinase 2 deficiency (TK2d), the journey has long been one of managing inevitable decline with no approved therapeutic options available in Europe. This extremely rare and severe genetic mitochondrial disease relentlessly

The journey following a stem cell transplant can be fraught with complications, none more debilitating than chronic graft-versus-host disease, a condition where donor immune cells relentlessly attack the recipient's body. This review assesses Rezurock (belumosudil) as a critical therapeutic option

With deep expertise in biopharma innovation and oncology research and development, Ivan Kairatov offers a unique perspective on the latest breakthroughs in cancer treatment. Today, we delve into the recent positive opinion from European regulators for AstraZeneca’s Imfinzi in combination with

For individuals grappling with the relentless and often disfiguring effects of cutaneous lupus erythematosus, the path to effective treatment has been long and fraught with limited options, but a significant development from Biogen offers a new beacon of hope. The U.S. Food and Drug Administration